Cytotoxicity and Biological Efficacy of Exendin-4-Encapsulated Solid Lipid Nanoparticles in INS-1 Cells

about

Cytotoxicity and Biological Efficacy of Exendin-4-Encapsulated Solid Lipid Nanoparticles in INS-1 Cells

Item

http://www.wikidata.org/entity/Q59114025

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2015

@uk

name

Cytotoxicity and Biological Ef ...... d Nanoparticles in INS-1 Cells

@en

Cytotoxicity and Biological Ef ...... d Nanoparticles in INS-1 Cells

@nl

type

Item

label

Cytotoxicity and Biological Ef ...... d Nanoparticles in INS-1 Cells

@en

Cytotoxicity and Biological Ef ...... d Nanoparticles in INS-1 Cells

@nl

prefLabel

Cytotoxicity and Biological Ef ...... d Nanoparticles in INS-1 Cells

@en

Cytotoxicity and Biological Ef ...... d Nanoparticles in INS-1 Cells

@nl

P1476

Cytotoxicity and Biological Ef ...... d Nanoparticles in INS-1 Cells

@en

P2093

Gongdeuk Bae

http://www.w3.org/2001/XMLSchema#string

Hee-Sook Jun

http://www.w3.org/2001/XMLSchema#string

Yoon Sin Oh

http://www.w3.org/2001/XMLSchema#string

Young Tag Ko

http://www.w3.org/2001/XMLSchema#string

P2860

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function.

Solid lipid nanoparticles: production, characterization and applications.

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.

Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4

Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.

Interleukin-6 treatment induces beta-cell apoptosis via STAT-3-mediated nitric oxide production.

pH-sensitive Eudragit nanoparticles for mucosal drug delivery.

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/753569

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

nanoparticle